B. Med. Sc. (1st class Honors), M.B.B.S. (Medicine), Ph.D. (Medical Genetics)
Professor Teh obtained his MD (1992) from the University of Queensland, Australia and his PhD (1997) from the Karolinska Institute, Sweden. He is currently the Deputy Chief Executive Officer (Research) of the National Cancer Centre of Singapore, and Director of SingHealth Duke-NUS Institute of Biodiversity Medicine (BD-MED).
He is a past and present member of the editorial boards / editor of Lancet Oncology, Cancer Research, Molecular Cancer Therapeutics, International Journal of Cancer and Science Translational Medicine. His laboratory has been focusing on Genomics and Epigenomics of Asian-Prevalent Cancers such as hepatobiliary cancer, herbal carcinogen-related cancer and breast fibroepithelial tumors. Dr Teh is a recipient of the 2015 Singapore President Science Award, 2018 AACR Team Science Award, and plenary lecturer at the 2019 AACR Annual Meeting.
Selected Publications (out of 416)
Subscribe to our mailing list to get the updates to your email inbox...